Cargando…
T Cell Recognition of Autoantigens in Human Type 1 Diabetes: Clinical Perspectives
Type 1 diabetes (T1D) is an autoimmune disease driven by the activation of lymphocytes against pancreatic β-cells. Among β-cell autoantigens, preproinsulin has been ascribed a key role in the T1D process. The successive steps that control the activation of autoreactive lymphocytes have been extensiv...
Autores principales: | Mallone, Roberto, Brezar, Vedran, Boitard, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140193/ https://www.ncbi.nlm.nih.gov/pubmed/21785617 http://dx.doi.org/10.1155/2011/513210 |
Ejemplares similares
-
To B or Not to B: (Anti)bodies of Evidence on the Crime Scene of Type 1 Diabetes?
por: Mallone, Roberto, et al.
Publicado: (2011) -
Viral infection prevents diabetes by inducing regulatory T cells through NKT cell–plasmacytoid dendritic cell interplay
por: Diana, Julien, et al.
Publicado: (2011) -
Preclinical Models to Evaluate the Human Response to Autoantigen and Antigen-Specific Immunotherapy in Human Type 1 Diabetes
por: Houeiss, Pamela, et al.
Publicado: (2022) -
Antigen-Based Immune Therapeutics for Type 1 Diabetes: Magic Bullets or Ordinary Blanks?
por: Culina, Slobodan, et al.
Publicado: (2011) -
Antibodies Recognizing Mycobacterium avium paratuberculosis Epitopes Cross-React with the Beta-Cell Antigen ZnT8 in Sardinian Type 1 Diabetic Patients
por: Masala, Speranza, et al.
Publicado: (2011)